Literature DB >> 8985388

Tyrosine phosphorylation events during coxsackievirus B3 replication.

M Huber1, H C Selinka, R Kandolf.   

Abstract

In order to study cellular and viral determinants of pathogenicity, interactions between coxsackievirus B3 (CVB3) replication and cellular protein tyrosine phosphorylation were investigated. During CVB3 infection of HeLa cells, distinct proteins become phosphorylated on tyrosine residues, as detected by the use of antiphosphotyrosine Western blotting. Two proteins of 48 and 200 kDa showed enhanced tyrosine phosphorylation 4 to 5 h postinfection (p.i.), although virus-induced inhibition of cellular protein synthesis had already occurred 3 to 4 h p.i. Subcellular fractionation experiments revealed distinct localization of tyrosine-phosphorylated proteins of 48 and 200 kDa in the cytosol and membrane fractions of infected cells, respectively. In addition, in Vero cells infected with CVB3, echovirus (EV)11, or EV12, increased tyrosine phosphorylation of a 200-kDa protein was detected 6 h p.i. Herbimycin A, a specific inhibitor of Src-like protein tyrosine kinases, was shown to inhibit virus-induced tyrosine phosphorylations and to reduce the production of progeny virions. In contrast, in cells treated with the inhibitors staurosporine and calphostin C, the synthesis of progeny virions was not affected. Immunoprecipitation experiments suggested that the tyrosine-phosphorylated 200-kDa protein in CVB3-infected cells is of cellular origin. In summary, these investigations have begun to unravel the effect of CVB3 as well as EV11 and EV12 replication on cellular tyrosine phosphorylation and support the importance of tyrosine phosphorylation events for effective virus replication. Such cellular phosphorylation events triggered in the course of enterovirus infection may enhance virus replication.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8985388      PMCID: PMC191089     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Nerve growth factor rapidly stimulates tyrosine phosphorylation of phospholipase C-gamma 1 by a kinase activity associated with the product of the trk protooncogene.

Authors:  M L Vetter; D Martin-Zanca; L F Parada; J M Bishop; D R Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

Review 2.  Protein-tyrosine kinases.

Authors:  T Hunter; J A Cooper
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

3.  Phosphorylation of tyrosine residues of calmodulin in Rous sarcoma virus-transformed cells.

Authors:  Y Fukami; T Nakamura; A Nakayama; T Kanehisa
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

Review 4.  Is insulin-dependent diabetes mellitus caused by coxsackievirus B infection? A review of the epidemiologic evidence.

Authors:  E Barrett-Connor
Journal:  Rev Infect Dis       Date:  1985 Mar-Apr

5.  The tyrosine kinase lck is critically involved in the growth transformation of human B lymphocytes.

Authors:  R K Cheung; H M Dosch
Journal:  J Biol Chem       Date:  1991-05-15       Impact factor: 5.157

6.  Conversion of a human B cell lymphoma line by Epstein-Barr virus is associated with increased tyrosine phosphorylation of a 50 kilodalton cytosolic protein.

Authors:  J Lacy; A Bartiss; D L Coleman
Journal:  Virus Res       Date:  1991-06       Impact factor: 3.303

7.  RNA--protein interactions within the internal translation initiation region of encephalomyocarditis virus RNA.

Authors:  A V Borovjagin; M V Ezrokhi; V M Rostapshov; T F Bystrova; I N Shatsky
Journal:  Nucleic Acids Res       Date:  1991-09-25       Impact factor: 16.971

8.  Molecular cloning of the genome of a cardiotropic Coxsackie B3 virus: full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells.

Authors:  R Kandolf; P H Hofschneider
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

9.  Coxsackie B3 virus can replicate in cultured human foetal heart cells and is inhibited by interferon.

Authors:  R Kandolf; A Canu; P H Hofschneider
Journal:  J Mol Cell Cardiol       Date:  1985-02       Impact factor: 5.000

10.  Epidermal growth factor or okadaic acid stimulates phosphorylation of eukaryotic initiation factor 4F.

Authors:  R W Donaldson; C H Hagedorn; S Cohen
Journal:  J Biol Chem       Date:  1991-02-15       Impact factor: 5.157

View more
  9 in total

Review 1.  Virus-receptor interactions of coxsackie B viruses and their putative influence on cardiotropism.

Authors:  Hans-Christoph Selinka; Antje Wolde; Martina Sauter; Reinhard Kandolf; Karin Klingel
Journal:  Med Microbiol Immunol       Date:  2003-08-14       Impact factor: 3.402

2.  Cleavage of RasGAP and phosphorylation of mitogen-activated protein kinase in the course of coxsackievirus B3 replication.

Authors:  M Huber; K A Watson; H C Selinka; C M Carthy; K Klingel; B M McManus; R Kandolf
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

3.  Apoptosis in coxsackievirus B3-caused diseases: interaction between the capsid protein VP2 and the proapoptotic protein siva.

Authors:  A Henke; H Launhardt; K Klement; A Stelzner; R Zell; T Munder
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

4.  Effect of p38 mitogen-activated protein kinase on the replication of encephalomyocarditis virus.

Authors:  Kensuke Hirasawa; Angus Kim; Hye-Seung Han; Jaeseok Han; Hee-Sook Jun; Ji-Won Yoon
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

5.  Proteasome activator REGgamma enhances coxsackieviral infection by facilitating p53 degradation.

Authors:  Guang Gao; Jerry Wong; Jingchun Zhang; Ivy Mao; Jayant Shravah; Yan Wu; Allen Xiao; Xiaotao Li; Honglin Luo
Journal:  J Virol       Date:  2010-08-18       Impact factor: 5.103

6.  Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis.

Authors:  Mary Anne Opavsky; Tami Martino; Marlene Rabinovitch; Josef Penninger; Chris Richardson; Martin Petric; Cathy Trinidad; Lisa Butcher; Janice Chan; Peter P Liu
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

7.  Caspase activation and specific cleavage of substrates after coxsackievirus B3-induced cytopathic effect in HeLa cells.

Authors:  C M Carthy; D J Granville; K A Watson; D R Anderson; J E Wilson; D Yang; D W Hunt; B M McManus
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

8.  Tripeptidyl peptidase II serves as an alternative to impaired proteasome to maintain viral growth in the host cells.

Authors:  Jingchun Zhang; Jerry Wong; Guang Gao; Honglin Luo
Journal:  FEBS Lett       Date:  2010-12-08       Impact factor: 4.124

9.  The antiviral effect of jiadifenoic acids C against coxsackievirus B3.

Authors:  Miao Ge; Huiqiang Wang; Guijie Zhang; Shishan Yu; Yuhuan Li
Journal:  Acta Pharm Sin B       Date:  2014-07-16       Impact factor: 11.413

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.